Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$983M |
| 2 |
Meta Platforms (Facebook)
META
|
+$932M |
| 3 |
AbbVie
ABBV
|
+$883M |
| 4 |
Analog Devices
ADI
|
+$461M |
| 5 |
CRH
CRH
|
+$435M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$868M |
| 2 |
Texas Instruments
TXN
|
+$587M |
| 3 |
Advanced Micro Devices
AMD
|
+$531M |
| 4 |
Aon
AON
|
+$529M |
| 5 |
Johnson & Johnson
JNJ
|
+$527M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.5% |
| 2 | Financials | 18.41% |
| 3 | Healthcare | 14.02% |
| 4 | Industrials | 12.82% |
| 5 | Communication Services | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
IDEX
IEX
$17.3B
| $126M | 0.04% |
607,036
-511,408
| -46% | -$111M |
|
327
Legend Biotech
LEGN
$3.95B
| $125M | 0.04% |
1,867,032
+212,327
| +13% | +$14.7M |
|
328
Petrobras
PBR
$116B
| $125M | 0.04% |
8,321,128
-1,473,211
| -15% | -$21M |
|
329
Paylocity
PCTY
$8.14B
| $124M | 0.04% |
680,342
-212,446
| -24% | -$42.7M |
|
330
W.P. Carey
WPC
$16.4B
| $124M | 0.04% |
2,333,347
+341,662
| +17% | +$21.9M |
|
331
Ameren
AEE
$30.2B
| $123M | 0.04% |
1,637,819
-21,724
| -1% | -$1.77M |
|
332
Alnylam Pharmaceuticals
ALNY
$29.1B
| $122M | 0.04% |
688,228
+15,831
| +2% | +$3.02M |
|
|
GRP.U
333
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $122M | 0.04% |
2,292,686
+112,518
| +5% | +$6.37M |
|
334
Encompass Health
EHC
$12.6B
| $121M | 0.04% |
1,807,922
-356,074
| -16% | -$24.5M |
|
335
HubSpot
HUBS
$10.5B
| $119M | 0.04% |
241,203
+204,241
| +553% | +$107M |
|
336
Ascendis Pharma A/S
ASND
$16.7B
| $118M | 0.04% |
1,264,470
+176,948
| +16% | +$16.6M |
|
337
Newell Brands
NWL
$2.54B
| $118M | 0.04% |
13,086,983
+200,321
| +2% | +$1.99M |
|
338
NNN REIT
NNN
$8.99B
| $118M | 0.04% |
3,340,946
+45,541
| +1% | +$1.83M |
|
339
Bio-Rad Laboratories Class A
BIO
$9.27B
| $116M | 0.04% |
+323,717
| New | +$125M |
|
340
Jones Lang LaSalle
JLL
$16.8B
| $116M | 0.04% |
818,147
+66,014
| +9% | +$10.8M |
|
341
Albertsons Companies
ACI
$5.82B
| $115M | 0.04% |
5,073,421
-44,886
| -0.9% | -$1M |
|
342
Biogen
BIIB
$30.5B
| $115M | 0.04% |
446,602
+300,086
| +205% | +$80.3M |
|
|
CHX
343
DELISTED
ChampionX
CHX
| $114M | 0.04% |
3,192,116
-1,169,851
| -27% | -$41.6M |
|
344
MetLife
MET
$62.2B
| $113M | 0.04% |
1,801,568
-133,528
| -7% | -$8.32M |
|
345
Walmart Inc
WMT
$887B
| $109M | 0.04% |
2,035,686
-1,002,921
| -33% | -$53.4M |
|
346
CACI
CACI
$14B
| $108M | 0.04% |
345,209
+12,816
| +4% | +$4.29M |
|
347
DraftKings
DKNG
$11.7B
| $107M | 0.04% |
+3,643,873
| New | +$108M |
|
348
Host Hotels & Resorts
HST
$16.1B
| $107M | 0.04% |
6,657,066
-76,351
| -1% | -$1.27M |
|
349
General Mills
GIS
$19.5B
| $106M | 0.04% |
1,664,308
+150,318
| +10% | +$10.6M |
|
350
Delta Air Lines
DAL
$60.2B
| $106M | 0.04% |
2,870,350
+3,684
| +0.1% | +$160K |
|
Similar funds
Massachusetts Financial Services's Q3 2023 Portfolio in Review
As of Q3 2023, Massachusetts Financial Services held 881 positions worth $286B, down 6.2% from $305B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Massachusetts Financial Services's Q3 2023 filing shows 59 new, 333 increased, 435 reduced and 45 closed positions. Its largest new stake was CRH: 7,649,420 shares worth $419M. The largest sale was Merck, an estimated $868M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
- Massachusetts Financial Services's largest Q3 2023 buy was CRH: 7,649,420 shares worth $419M.
- Massachusetts Financial Services added most to Kenvue in Q3 2023, an estimated $983M increase.
- Massachusetts Financial Services's biggest Q3 2023 reduction was Merck, cutting an estimated $868M.
- Massachusetts Financial Services fully exited Black Knight, Inc. Common Stock in Q3 2023, selling an estimated $512M.
- Massachusetts Financial Services's ten largest holdings make up 19% of its $286B portfolio in Q3 2023.
- Massachusetts Financial Services opened 59 new positions and closed 45 in Q3 2023.
- Massachusetts Financial Services's portfolio value fell 6.2% quarter-over-quarter to $286B.
Based on Massachusetts Financial Services's 13F filing for Q3 2023, filed 8 Nov 2023.